Featured Speakers
Jerome Calmejane
Senior Director – GCP Quality Assurance/Inspection Management
Johnson & Johnson
John Daly
Risk Management Lead
UCB Biopharma
Nancy Dynes
Associate Director, Global Medical Quality Metrics
Eli Lilly
Alyssa Gateman
Senior Advisor, Quality Assurance, Yale Center for Clinical Investigation, Executive Director, Clinical Trials Officer
Yale Cancer Center
Kristen Giessler
Senior Clinical Data Scientist
Alkermes
Gayle Hamilton
Director, RBQM, Digital Trial Management Suite
IQVIA Technologies
Anne Marie Inglis
Executive Director, Clinical Operations, Affinivax
GSK-Affinivax
Adrian Kizewski
Associate Director, RBQM, Digital Trial Management Suite
IQVIA Technologies
Ashley Mischitelle
Principal Data Sciences Product Leader
Roche
Esther Huffman OKeefe
Director, Adaptive Monitoring Excellence, Clinical Quality Management | Innovation & Data | Global Development Office
Takeda Pharmaceuticals International
Michel Reid
Senior Director and Head, Global Demographics and Diversity
GSK
Karen McCarthy Schau
Director, Risk Based Study Management
Vertex Pharmaceuticals
Rob Staszewski
Senior Manager, Clinical Systems & Informatics
United Therapeutics Corporation
Shawntel Swannack
Director, Central Monitoring and Data Analytics
GSK
Katherine Taylor
Senior Director, Head Risk Evaluation & Adaptive Integrated Monitoring
Merck (Conference Chair)
Lee Truax-Bellows
CEO
LTB GCP Consulting LLC
Erika Vento-Gaudens
Director, Global Clinical Study Operations
Guardant Health
Michael Walega
Head of Centralized Monitoring
Bristol-Myers Squibb
Michele Weitz
GCP Vision Consulting
Mandy White
Senior Quality Lead
Genentech
Judyth Zahora
Senior Director, Global Quality Systems & Process Improvement
Agenus